4890 SB (Requip 0.25 mg)
Generic Name: ropinirole
Pill imprint 4890 SB has been identified as Requip 0.25 mg.
Requip is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ropinirole
- Imprint:
- 4890 SB
- Strength:
- 0.25 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Five-sided
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4890
- Inactive Ingredients:
- croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68387-0198 | Keltman Pharmaceuticals Inc (repackager) |
| 35356-0522 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More about Requip (ropinirole)
Consumer resources
- Other brands: Requip XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
